Adding the "medicines' back into personalized medicine to improve cancer treatment outcomes

被引：3
|
作者：
Martin, Jennifer H. [1 ,2 ]
Phillips, Elizabeth [3 ,4 ]
Thomas, David [5 ,6 ]
Somogyi, Andrew A. [7 ,8 ]
机构：
[1] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW 2308, Australia
[2] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia
[3] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA
[4] Murdoch Univ, Inst Immunol & Infect Dis, Murdoch, WA 6150, Australia
[5] St Vincents Hosp, Garvan Inst Med Res, Kinghorn Canc Ctr, Darlinghurst, NSW 2010, Australia
[6] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia
[7] Univ Adelaide, Fac Hlth Sci, Discipline Pharmacol, Adelaide, SA 5001, Australia
[8] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 2015年 / 80卷 / 05期
关键词：
CELL LUNG-CANCER; INHIBITION; ABACAVIR; KINASE; TUMORS;
D O I：
10.1111/bcp.12690
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：929 / 931
页数：3
相关论文
共 50 条
  • [21] Shaping the future of precision oncology: Integrating circadian medicine and mathematical models for personalized cancer treatment
    Hesse, Janina
    Nelson, Nina
    Relogio, Angela
    CURRENT OPINION IN SYSTEMS BIOLOGY, 2024, 37
  • [22] Engineering neoantigen vaccines to improve cancer personalized immunotherapy
    Liu, Zaoqu
    Lv, Jinxiang
    Dang, Qin
    Liu, Long
    Weng, Siyuan
    Wang, Libo
    Zhou, Zhaokai
    Kong, Ying
    Li, Huanyun
    Han, Yilin
    Han, Xinwei
    INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2022, 18 (15): : 5607 - 5623
  • [23] Epigenetic alterations in cancer and personalized cancer treatment
    Miozzo, Monica
    Vaira, Valentina
    Sirchia, Silvia Maria
    FUTURE ONCOLOGY, 2015, 11 (02) : 333 - 348
  • [24] Precision medicine: role of pathology in diagnosis and personalized treatment
    Quiroz, Tania S.
    Las Heras, Facundo
    REVISTA MEDICA CLINICA LAS CONDES, 2022, 33 (01): : 36 - 43
  • [25] Lung Cancer Organoids: The Rough Path to Personalized Medicine
    Rossi, Rachele
    De Angelis, Maria Laura
    Xhelili, Eljona
    Sette, Giovanni
    Eramo, Adriana
    De Maria, Ruggero
    Cesta Incani, Ursula
    Francescangeli, Federica
    Zeuner, Ann
    CANCERS, 2022, 14 (15)
  • [26] KRAS and colorectal cancer: an important step to the personalized medicine
    Lamoril, J.
    Ameziane, N.
    Deybach, J. -C.
    Bouizegarene, P.
    Bogard, M.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2009, 24 (04): : 196 - 209
  • [27] Personalized Cancer Models for Target Discovery and Precision Medicine
    Grandori, Carla
    Kemp, Christopher J.
    TRENDS IN CANCER, 2018, 4 (09): : 634 - 642
  • [28] Prediction of Cancer Drug Resistance and implications for Personalized Medicine
    Volm, Manfred
    Efferth, Thomas
    FRONTIERS IN ONCOLOGY, 2015, 5
  • [29] Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine
    Masucci, Michele
    Karlsson, Claes
    Blomqvist, Lennart
    Ernberg, Ingemar
    JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (06):
  • [30] Building a Personalized Medicine Infrastructure at a Major Cancer Center
    Meric-Bernstam, Funda
    Farhangfar, Carol
    Mendelsohn, John
    Mills, Gordon B.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15) : 1849 - 1857
12345